Recerca

Farmacologia molecular i teràpies experimentals

Buscador de publicacions

Publicacions

  • Galán V, Beléndez C, Echecopar C, Estival P, Sissini L, Olivas R, Bueno D, Molina B, Fuentes C, Regueiro A, Benítez I, Plaza M, Margarit A, Rifón J, Pascual A, Palomo P, Urtasun N, Fuster JL, de Heredia CD, Navarro JMF, Vicent MG, Ruz B and Martínez AP.

    Treosulfan-Based Conditioning Regimen In Pediatric Hematopoietic Stem Cell Transplantation: A Retrospective Analysis on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC).

    Transplantation and Cellular Therapy . 29(11): .

    [doi:10.1016/j.jtct.2023.08.016]

  • Pena-Rodriguez, E, García-Vega L, Lajarin Reinares M, Pastor-Anglada M, Perez-Torras S and Fernandez-Campos, F.

    Latanoprost-Loaded Nanotransfersomes Designed for Scalp Administration Enhance Keratinocytes Proliferation

    MOLECULAR PHARMACEUTICS . 20(5): 2317-2325.

    [doi:10.1021/acs.molpharmaceut.2c00796]

  • Brunet M and Pastor-Anglada M.

    Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics.

    Pharmaceutics . 14(9): 1755. Nº de cites: 3

    [doi:10.3390/pharmaceutics14091755]

  • Pastor-Anglada M, Mata A and Perez-Torras S.

    Inborn Errors of Nucleoside Transporter (NT)-Encoding Genes (SLC28 and SLC29)

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 23(15): 8770. Nº de cites: 3

    [doi:10.3390/ijms23158770]

  • Boces-Pascual, C, Mata A, Martin-Satue, M, Boix, L, Gironella, M, Pastor-Anglada M and Perez-Torras S.

    OncomiRs miR-106a and miR-17 negatively regulate the nucleoside-derived drug transporter hCNT1

    CELLULAR AND MOLECULAR LIFE SCIENCES . 78(23): 7505-7518. Nº de cites: 2

    [doi:10.1007/s00018-021-03959-8]

  • Pena-Rodríguez E, Mata A, García-Vega L, Pérez-Torras S and Fernández-Campos F.

    The Physicochemical, Biopharmaceutical, and In Vitro Efficacy Properties of Freeze-Dried Dexamethasone-Loaded Lipomers.

    Pharmaceutics . 13(8): 1322. Nº de cites: 4

    [doi:10.3390/pharmaceutics13081322]

  • Pena-Rodríguez E, Lajarin-Reinares M, Mata-Ventosa A, Perez-Torras S and Fernández-Campos F.

    Dexamethasone-Loaded Lipomers: Development, Characterization, and Skin Biodistribution Studies.

    Pharmaceutics . 13(4): 533. Nº de cites: 7

    [doi:10.3390/pharmaceutics13040533]

  • Guillén-Gómez E, Silva I, Serra N, Caballero F, Leal J, Breda A, San Martín R, Pastor-Anglada M, Ballarín JA, Guirado L and Díaz-Encarnación MM.

    From Inflammation to the Onset of Fibrosis through A(2A) Receptors in Kidneys from Deceased Donors.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 21(22): . Nº de cites: 4

    [doi:10.3390/ijms21228826]

  • Jaramillo AC, Hubeek I, Broekhuizen R, Pastor-Anglada M, Kaspers GJL, Jansen G, Cloos J and Peters GJ.

    Expression of the nucleoside transporters hENT1 (SLC29) and hCNT1 (SLC28) in pediatric acute myeloid leukemia.

    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS . 39(10-12): 1379-1388. Nº de cites: 6

    [doi:10.1080/15257770.2020.1746803]

  • Perello C, Català-Temprano A, Caviedes L, Vega-García N, Camós-Guijosa M, Perez-Torras S and Pastor-Anglada M.

    FMS-like tyrosine kinase 3 (FLT3) modulates key enzymes of nucleotide metabolism implicated in cytarabine responsiveness in pediatric acute leukemia

    PHARMACOLOGICAL RESEARCH . 151: 104556-104556. Nº de cites: 5

    [doi:10.1016/j.phrs.2019.104556]